Mass Tort Attorney Indiana (2026 Guide)

If you or a family member suffered serious harm from a defective product, dangerous drug, or toxic chemical exposure in Indiana, understanding your legal rights in 2026 is the critical first step. Mass tort litigation allows hundreds or thousands of injured individuals to pursue justice against the same corporate defendant while each victim retains a completely individual case and recovers damages based on their unique injuries. A qualified mass tort attorney Indiana residents trust can evaluate whether your claim qualifies under the Indiana Product Liability Act, calculate your potential compensation, and guide you through one of the most complex areas of civil law in the state.

What Is Mass Tort Litigation and How Does It Work in Indiana in 2026?

Mass tort litigation arises when a single defective product, dangerous pharmaceutical, or toxic substance injures a large number of people. Unlike a class action lawsuit where all plaintiffs share one collective recovery, a mass tort case treats every plaintiff as an individual. Each person files their own lawsuit, presents their own medical evidence, and receives damages calculated specifically around their personal losses. This distinction matters enormously: a plaintiff with Stage IV ovarian cancer from a chemical exposure recovers far more than a plaintiff with a minor rash, even though both claims arise from the same defendant and the same product.

In Indiana, mass tort cases often travel through the federal Multidistrict Litigation system. Under 28 U.S.C. § 1407, the Judicial Panel on Multidistrict Litigation can transfer related federal cases from different districts into one court for consolidated pretrial proceedings. This prevents duplicative discovery, inconsistent rulings, and overwhelming individual court dockets. Indiana has hosted approximately 14 or more MDL actions over four decades, including the landmark Bridgestone/Firestone tire recall MDL before Judge Sarah Evans Barker in the Southern District of Indiana, which involved roughly 850 cases alleging tread separation causing Ford Explorer rollovers. For Indiana residents pursuing claims, working with a local mass tort attorney Indiana who understands both federal MDL procedures and Indiana-specific tort law creates a distinct advantage when your case returns to state court or proceeds to a bellwether trial.

At the state level, Indiana does not have a dedicated statewide mass tort panel equivalent to an MDL. Instead, state-level consolidation vests in the local trial judge before whom the first case was filed. This means coordination is judge-dependent and varies by county, making early legal representation especially important for Indiana plaintiffs who want their cases managed efficiently from the start.

Indiana Product Liability Act: The Legal Foundation for Mass Tort Claims in 2026

Nearly every product-related mass tort claim in Indiana is governed by the Indiana Product Liability Act, codified at IC 34-20. The IPLA is the exclusive vehicle for seeking compensation when a defective product causes physical harm. It covers three main categories of defect: manufacturing defects, design defects, and failure-to-warn claims. Critically, the IPLA applies strict liability only to manufacturing defect claims under IC 34-20-2-3. If you allege that a product’s design was inherently dangerous or that the manufacturer failed to warn you of a known risk — as is common in pharmaceutical and medical device mass torts — you must prove negligence, not merely that the product caused your harm. This higher burden separates Indiana from some other states and makes expert testimony and thorough case preparation essential.

Indiana’s IPLA also provides complete defenses that corporate defendants frequently deploy. Under principles established in cases like Campbell Hausfeld/Scott Fetzer, a manufacturer can defeat liability entirely by proving incurred risk (the plaintiff voluntarily assumed a known hazard), product misuse, or product alteration. Additionally, Indiana recognizes a state-of-the-art defense that creates a rebuttable presumption that a product was not defective if it conformed to recognized safety standards at the time of manufacture. Your mass tort attorney Indiana must be prepared to rebut this presumption with independent scientific evidence, internal corporate documents, and expert witnesses who can demonstrate the defendant knew of risks that the official standards did not yet reflect.

One of the most significant IPLA provisions affecting mass tort plaintiffs involves seller liability. Indiana provides innocent seller protection under IC 34-20-2-3, meaning retailers and distributors cannot be held strictly liable unless they are also the manufacturer of the defective product. In most pharmaceutical and consumer product mass torts, this means the lawsuit must target the original manufacturer, not the pharmacy or store where the product was purchased.

Indiana Statute of Limitations and Statute of Repose: Deadlines That Can End Your Case

Time limits in Indiana product liability cases are among the most unforgiving in the country. Understanding both the statute of limitations and the statute of repose is essential before consulting a mass tort attorney Indiana for the first time.

Under IC 34-20-3-1, Indiana imposes a two-year statute of limitations on product liability claims. The clock starts running from the date the injury accrues — which, under the discovery rule applicable in toxic exposure and product liability cases, means the date the plaintiff knew or reasonably should have known of the injury and its connection to the product. This discovery rule is particularly important in mass torts involving pharmaceutical drugs, chemical exposure, and toxic substances, where symptoms may develop years after initial exposure.

However, the statute of limitations operates alongside a separate and more rigid ten-year statute of repose. Under IC 34-20-3-1, a product liability claim is completely barred if the injury occurs more than ten years after the product was first delivered to the initial user or consumer — even if the plaintiff only just discovered the injury. There is one narrow exception: if the injury first occurs between eight and ten years after delivery, the plaintiff still receives a full two years from the accrual date to file. Asbestos-related claims operate under separate rules codified at IC 34-20-3-2, reflecting the unique latency period of asbestos diseases like mesothelioma. Indiana’s general personal injury statute of limitations under IC 34-11-2-4 is also two years, and claims against government entities carry additional notice requirements — 180 days for city or county claims and 270 days for state claims under the Indiana Tort Claims Act at IC 34-13-3-6.

Indiana Comparative Fault and Damages Cap Rules in 2026

Indiana follows modified comparative fault under IC 34-51-2. Under this system, a plaintiff’s damages are reduced proportionally by their percentage of fault. If a jury finds a plaintiff 20% responsible for their own injury, they recover 80% of the total damages award. However, if the plaintiff is found to be more than 50% at fault, they recover nothing. This threshold is critically important in mass tort cases where corporate defendants routinely argue that the plaintiff misused the product, ignored warnings, or had pre-existing conditions that contributed to the injury.

The practical impact of comparative fault is demonstrated vividly in Indiana’s notable verdicts. In a 2024 Lake County case, a Marion County jury awarded $60.7 million to motorcyclist Chris Dugan against Tesla after finding a Tesla truck driver 70% at fault for an accident that left the victim with the mental capacity of a ten-year-old and a partial foot amputation. Because the Tesla driver bore the majority of fault, the final award was adjusted to approximately $42.5 million under Indiana’s comparative fault framework — ranking third on CVN’s list of top plaintiff verdicts nationally in 2024. If you are calculating your potential recovery after a catastrophic brain or cognitive injury from a defective product, a brain injury calculator can help you understand the range of compensation before you speak with an attorney.

Indiana also caps punitive damages under IC 34-51-3-4. Punitive damages cannot exceed three times the compensatory damages award or $50,000, whichever is greater. Further, 75% of any punitive award is paid into the Indiana Violent Crime Victims Compensation Fund rather than to the plaintiff. This means that even in egregious corporate misconduct cases, the actual punitive damages a plaintiff receives are substantially limited. Medical malpractice claims involving defective drugs or devices are subject to their own separate damages structure: total damages are capped at $1.8 million with individual provider liability capped at $500,000 for incidents occurring after 2019. Use our medical malpractice calculator to estimate your recovery in device-related injury claims before engaging counsel.

Active Mass Tort Cases Affecting Indiana Plaintiffs in 2026

Several high-profile mass tort litigations are actively accepting Indiana plaintiffs in 2026. Each involves a different product category, injury type, and litigation posture, but all share the common feature of a corporate defendant allegedly placing profits ahead of consumer safety.

• Hair Relaxer MDL: Women who used chemical hair relaxers and were subsequently diagnosed with uterine or ovarian cancer are filing claims alleging that manufacturers concealed carcinogenic ingredient risks.
• Depo-Provera Meningioma MDL: Long-term users of the contraceptive injection Depo-Provera who developed meningioma brain tumors are pursuing claims against Pfizer for failure to warn of the elevated tumor risk.
• Hernia Mesh Litigation: Patients who experienced chronic pain, infection, adhesion, or organ perforation after hernia mesh implantation continue to pursue claims against multiple manufacturers.
• Roundup/Glyphosate Litigation: Individuals diagnosed with non-Hodgkin’s lymphoma after repeated exposure to Roundup herbicide are asserting claims against Bayer/Monsanto, with thousands of Indiana agricultural workers potentially qualifying.
• Paraquat Parkinson’s Disease MDL: Farm workers and rural residents exposed to Paraquat herbicide who developed Parkinson’s disease are filing in the consolidated MDL, as scientific evidence of a neurological link continues to mount.
• AFFF Firefighting Foam PFAS Claims: Military personnel, airport workers, and firefighters exposed to AFFF containing PFAS “forever chemicals” are pursuing claims for cancers and other serious health conditions.
• 3M Combat Earplugs: Veterans who used dual-ended 3M earplugs during military service and suffered hearing loss or tinnitus continue pursuing individual claims after the 3M bankruptcy resolution process.

Indiana residents injured in any of these active litigations should use our mass tort settlement calculator to get a preliminary estimate of compensation based on injury severity, diagnosis, and exposure history. In fatal mass tort cases, surviving family members pursuing wrongful death claims can also reference a wrongful death calculator to understand the economic and non-economic value of their loss.

Indiana Mass Tort Legal Data Table: Key Laws, Deadlines, and Damages Rules

How MDL Proceedings Work for Indiana Mass Tort Plaintiffs

For Indiana residents injured by nationally distributed products, the federal MDL system is the most likely procedural home for their claims. Understanding how MDL works removes confusion and helps plaintiffs set realistic expectations for the timeline and process of their case. The Judicial Panel on Multidistrict Litigation, operating under federal court authority, evaluates petitions to consolidate related cases and designates a single transferee court. That court oversees all pretrial discovery, motion practice, and case management for the consolidated docket.

Once transferred, the MDL judge appoints a Plaintiffs Steering Committee — a group of experienced attorneys who coordinate all plaintiffs’ litigation strategy, conduct shared discovery, and negotiate with defense counsel on behalf of the entire plaintiff group. Individual plaintiffs are represented by their own retained counsel, including their local mass tort attorney Indiana who monitors their specific case and ensures their individual damages profile is preserved throughout the MDL process. This is a critical distinction: your attorney is not the PSC. The PSC handles global strategy; your attorney handles your individual claim and communicates your specific medical history, economic losses, and damages evidence to the central litigation team.

Bellwether trials are a defining feature of MDL litigation. The MDL judge selects a small number of representative cases to proceed to trial first. These bellwether results — whether verdicts or settlements — send powerful signals to defendants about their exposure risk and often catalyze global settlement negotiations. The 3M Combat Earplug MDL and the Roundup litigation both used bellwether trials to generate billions in settlements. Indiana plaintiffs should understand that their individual case may not go to trial, but that the bellwether process directly determines the settlement value range that applies to their claim.

Evaluating Your Mass Tort Claim Value: What Factors Drive Indiana Settlements

Determining the value of a mass tort claim in Indiana in 2026 depends on a combination of injury-specific, economic, and litigation factors that vary significantly from plaintiff to plaintiff. While national settlement grids and administrative compensation programs often establish baseline values for common diagnoses, Indiana’s comparative fault rules and punitive damages caps add state-specific layers that affect the final recovery. Consulting a personal injury settlement calculator early in the process helps Indiana plaintiffs understand the range of compensation before entering formal legal proceedings.

The most important factors affecting mass tort settlement value in Indiana include: the severity and permanency of the diagnosed injury; the strength of the causal link between the product and the injury supported by published medical literature; the duration and intensity of exposure; the plaintiff’s age, pre-injury income, and anticipated future medical costs; and whether the defendant’s internal documents reveal knowledge of the risk that was concealed from consumers or regulators. Cases involving demonstrable corporate misconduct — suppressed safety studies, falsified clinical trial data, deliberate regulatory evasion — tend to generate the highest settlements and are the cases where punitive damages arguments, even if ultimately capped, exert significant pressure on defendants during negotiations.

Indiana’s $49.65 million gross settlement from the State Fair stage collapse and the $42.5 million Dugan v. Tesla verdict both illustrate that Indiana juries and courts are capable of delivering substantial awards when liability is clear and injuries are severe. A knowledgeable mass tort attorney Indiana will use comparable state verdicts, national MDL settlement matrices, and the specific facts of your injury to develop a realistic damages picture before any settlement discussions begin.

Choosing the Right Mass Tort Attorney in Indiana for 2026

Not every personal injury attorney has the resources, expertise, or national network required to effectively handle a mass tort claim. Mass tort litigation demands familiarity with federal MDL procedures, access to the scientific and medical literature supporting causation, coordination with PSC leadership teams, and the financial capacity to fund long-running complex litigation. When evaluating a mass tort attorney Indiana residents should consider, look for demonstrated experience in product liability and pharmaceutical litigation specifically, membership or affiliation with MDL leadership teams, and a track record of successfully resolving claims — not just filing them.

Indiana is home to several firms recognized for complex civil litigation. Best Law Firms 2025 rankings highlighted firms including Hovde Dassow + Deets, CohenMalad LLP, Williams Law Group, Pavlack Law, Wagner Reese, and Wilson Kehoe Winingham for plaintiff-side civil work. CohenMalad LLP has secured significant class and mass recovery outcomes, including a successful action against the Indiana BMV for overcharging drivers and recoveries from the Indiana Department of Child Services involving adoption subsidies. Plews Shadley Racher & Braun obtained a defense judgment in a billion-dollar toxic tort case — illustrating the caliber of defense representation Indiana mass tort plaintiffs face. When the opposing counsel is that sophisticated, your mass tort attorney Indiana must be equally formidable.

Before retaining any attorney, confirm that your claim falls within the applicable statute of limitations. The two-year clock under IC 34-20-3-1 and the absolute ten-year statute of repose mean that delay is never neutral in Indiana product liability cases. Even if you only recently connected your diagnosis to the product — triggering the discovery rule — the repose period may independently cut off your right to sue. Getting a case evaluation promptly in 2026 is not just advisable; for some Indiana plaintiffs, it is the difference between compensation and a barred claim.

Indiana Mass Tort FAQs for 2026

How long do I have to file a mass tort lawsuit in Indiana in 2026?

Under IC 34-20-3-1, Indiana imposes a two-year statute of limitations on product liability claims, running from the date you knew or reasonably should have known of your injury and its connection to the product. However, a separate ten-year statute of repose bars all claims if the injury occurs more than ten years after the product was delivered to its initial user, regardless of when you discovered the harm. Asbestos claims have separate rules under IC 34-20-3-2. Because these deadlines are absolute, you should consult a mass tort attorney Indiana as soon as you identify a potential product-related injury.

What is the difference between an MDL and a class action lawsuit in Indiana?

In a class action, all plaintiffs are grouped into one collective case and share a single recovery divided among the group. In a Multidistrict Litigation, each plaintiff retains their own individual lawsuit with unique damages calculated around their specific injuries. The MDL process consolidates only the pretrial phase for efficiency under 28 U.S.C. § 1407. Indiana plaintiffs in an MDL still receive individual settlements or verdicts — a plaintiff with severe cancer from chemical exposure recovers far more than a plaintiff with minor symptoms, even in the same MDL. This individual damages structure is one of the primary reasons mass torts typically generate larger per-plaintiff recoveries than class actions.

Can Indiana’s comparative fault rule reduce or eliminate my mass tort recovery?

Yes. Indiana follows modified comparative fault under IC 34-51-2. If a jury finds that you were partially responsible for your injury — for example, by ignoring product warnings, using a product in an unintended way, or continuing use after you knew of a risk — your damages award is reduced by your percentage of fault. If your fault exceeds 50%, you recover nothing. Corporate defendants in Indiana mass torts routinely argue incurred risk and product misuse to shift fault onto the plaintiff. An experienced mass tort attorney Indiana will anticipate these arguments and build a case strategy that minimizes comparative fault findings.

Are punitive damages available in Indiana mass tort cases, and are they capped?

Punitive damages are available in Indiana mass tort cases involving egregious corporate misconduct, such as concealment of known product risks. However, under IC 34-51-3-4, punitive damages are capped at three times the compensatory damages award or $50,000, whichever is greater. Additionally, 75% of any punitive award is paid into the Indiana Violent Crime Victims Compensation Fund rather than to the plaintiff. While punitive damages can still exert significant settlement leverage in cases with strong corporate misconduct evidence, Indiana plaintiffs should understand that the net punitive recovery they actually receive is substantially smaller than the headline number.

What types of mass tort claims are currently active for Indiana residents in 2026?

Indiana residents have active mass tort eligibility in multiple ongoing litigations in 2026, including the hair relaxer MDL (uterine and ovarian cancer), the Depo-Provera meningioma MDL, hernia mesh litigation, Roundup/glyphosate non-Hodgkin’s lymphoma claims, the Paraquat Parkinson’s disease MDL, AFFF firefighting foam PFAS cancer claims, and residual 3M combat earplug hearing loss claims for veterans. Each litigation has its own eligibility criteria, diagnosis requirements, and exposure timelines. A qualified mass tort attorney Indiana can evaluate your medical history and exposure facts to determine which active litigations you may qualify for and ensure your claim is filed before applicable deadlines.